Onyx Pharmaceuticals Announces FDA Standard Review Designation of Carfilzomib New Drug Application for the Treatment of Relapsed and Refractory Multiple Myeloma

2011-12-11 20:00 SOUTH SAN FRANCISCO, Calif., Dec. 11, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced today that the U.S. Food and Drug Administration (FDA) has granted Standard Review designation to the New Drug Application (NDA) for carfilzomib for the potential treatment of patients with relapsed and refractory multiple myeloma. The Prescription Drug User Fee Act (PDUFA) date for completion of review by the FDA of the NDA is July 27, 2012.In the NDA filing designation letter from the...

TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting

2011-12-11 19:30 MALVERN, Pa., Dec. 11, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego. The study, conducted at The University of Texas M. D. Anderson Cancer Center, demonstrated that TL32711 induces apoptosis in acute myeloid leukemia (AML) cells, including AML stem...

American Film Institute Announces AFI AWARDS 2011 Official Selections

2011-12-11 17:06 LOS ANGELES, Dec. 11, 2011 /PRNewswire-USNewswire/ -- The American Film Institute (AFI) today announced the official selections of AFI AWARDS 2011 – the awards season event favored by artists and entertainment executives for its intimacy and collaborative recognition – that records the year's most outstanding achievements in film, television and other forms of the moving image arts.  AFI AWARDS is the only national recognition that honors the community's creative ensembles as a whole, acknowledg...